Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07726783.9Aexternal-prioritypatent/EP1999114B1/en
Application filed by F. Hoffmann-La Roche AgfiledCriticalF. Hoffmann-La Roche Ag
Publication of CY1116777T1publicationCriticalpatent/CY1116777T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Στο παρόν παρέχονται ενώσεις του τύπου (I) καθώς και φαρμακευτικώς αποδεκτά άλατα αυτών, όπου οι υποκατάστατες είναι όπως εκείνοι που αποκαλύπτονται στην περιγραφή. Αυτές οι ενώσεις, και οι φαρμακευτικές συνθέσεις που τις περιέχουν, είναι χρήσιμες για τη θεραπευτική αντιμετώπιση νόσων όπως, για παράδειγμα, ο σακχαρώδης διαβήτης τύπου II και το μεταβολικό σύνδρομο.Hereinafter provided are compounds of formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
CY20151100895T2006-03-222015-10-06
PYRAZOLA AS 11bHSD1
CY1116777T1
(en)
1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus.
NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF